Marc-Oliver Grimm (@grimm_mo) profile picture

Marc-Oliver Grimm

@grimm_mo

Marc-Oliver Grimm

 Jena
Joined December 2017
  • Tweets131
  • Following21
  • Followers159
Now online at European Urology: Impact of prior cytoreductive nephrectomy in patients receiving Axitinib+Avelumab vs Sunitinib in JAVELIN RENAL 101 authors.elsevier.com/sd/arti…
2
7
285
Now online at Lancet Oncology - final results of TITAN-RCC demonstrating added value of ipilimumab in RCC. authors.elsevier.com/a/1hw4d…
1
4
10
687
Now published online in #LancetOncology: The second line cohort from our tailored immunotherapy approach with nivolumab in mUC. authors.elsevier.com/a/1ggI0…
4
108
Updated DFS analysis by PD-L1 scores from CheckMate 274 now online in #EuropeanUrology: May help to identify more patients who benefit from adjuvant nivo in UC. authors.elsevier.com/sd/arti…
1
1
62
Great news for our mCSPC patients: positive #CHMP opinion for #darolutamide in mCSPC in combination with Docetaxel and ADT. Triplet improves OS vs. Docetaxel+ADT alone. Now looking forward to further improvement with ARASAFE (NCT05676203).
2
162
Bad news for our prostate cancer patients: Pembro+Olaparib fails in mCRPC. KEYLINK-010 stopped early after interim analysis. firstwordpharma.com/story/55…
Keytruda, Lynparza combo misses main goals of prostate cancer trial

Keytruda, Lynparza combo misses main goals of prostate cancer trial

Merck & Co. said Tuesday that the Phase III KEYLYNK-010 trial investigating Keytruda (pembrolizumab) plus Lynparza (olaparib) for certain patients with prostate cancer will be stopped for futil...

firstwordpharma.com
Tailored immunotherapy approach with Nivo (+/- Nivo+Ipi boosts) shows meaningful clinical activity in 1st line mUC: TITAN-TCC paper now online at JCO: ascopubs.org/doi/pdf/10.1200…
2
3
New data from CheckMate 214: Nephrectomy vs. primary tumor in place in mRCC authors.elsevier.com/c/1e1XT…
1
How to Deal with Renal Cell Carcinoma >7 cm: Radical Surgery Not everything that is technically feasible should be done ! sciencedirect.com/science/ar…
Logged on to ManyCam.com. ManyCam adds cool free effects to your webcam and more.
Geschafft - die aktualisierte S3 Leitlinie Prostatakarzinom ist raus ! urologenportal.de/pressebere…
DGU (@DGUrologie) profile pictureDGU@DGUrologie14 May 2021
Umfangreiches Update der S3-Leitlinie zum #Prostatakarzinom jetzt online #dgu21 @amerseburger @GeSRU_de @DKG_Berlin @KrebsNRW @BrbgKG @HKSH_BV @bps_2000 @Krebshilfe_Bonn @UrologieAlle @lpsnrw @Uroweb @EAUYAUrology @EAU_Uroonco @eau_yuo urologenportal.de/pressebere…
Image from DGU (@DGUrologie)
Why chemoimmunotherapy fails in mUC.....Re: Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial... sciencedirect.com/science/ar…
Immune checkpoint inhibitor therapy not superior to chemotherapy in untreated metastatic urothelial cancer. DANUBE did not meet primary endpoint. astrazeneca.com/content/astr…

No more items